| |
|
|
|
|
|
|
|||
|
Blood, 20 August 2009, Vol. 114, No. 8, pp. 1553-1562. Prepublished online as a Blood First Edition Paper on June 19, 2009; DOI 10.1182/blood-2009-02-206193.
IMMUNOBIOLOGY Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response1 Immunology Laboratory and 2 Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; 3 US Military HIV Research Program, Rockville, MD; 4 Department of Medical Biochemistry and Immunology, Cardiff University School of Medicine, Cardiff, United Kingdom; 5 National Institute for Medical Research-Mbeya Medical Research Programme, Referral Hospital, Mbeya, Tanzania; and 6 Department of Infectious Diseases and Tropical Medicine, Klinikum of University of Munich, Munich, Germany Human immunodeficiency virus-1 subtypes A and C differ in the highly conserved Gag-TL9 epitope at a single amino acid position. Similarly, the TL9 presenting human leukocyte antigen (HLA) class I molecules B42 and B81 differ only at 6 amino acid positions. Here, we addressed the influence of such minor viral and host genetic variation on the TL9-specific CD8 T-cell response. The clonotypic characteristics of CD8 T-cell populations elicited by subtype A or subtype C were distinct, and these responses differed substantially with respect to the recognition and selection of TL9 variants. Irrespective of the presenting HLA class I molecule, CD8 T-cell responses elicited by subtype C exhibited largely comparable TL9 variant cross-recognition properties, expressed T-cell receptors that used almost exclusively the TRBV 12-3 gene, and selected for predictable patterns of viral variation within TL9. In contrast, subtype A elicited TL9-specific CD8 T-cell populations with completely different, more diverse TCRBV genes and did not select for viral variants. Moreover, TL9 variant cross-recognition properties were extensive in B81+ subjects but limited in B42+ subjects. Thus, minor viral and host genetic polymorphisms can dramatically alter the immunologic and virologic outcome of an epitope-specific CD8 T-cell response.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||